Results 171 to 180 of about 9,257 (204)
Some of the next articles are maybe not open access.
2016
The subcutaneous abdominal fat comprehends two-thirds of the total abdominal fat, for being more abundant than visceral fat; it has a more important role in endocrine function. Subcutaneous fat removal by liposuction has an esthetic effect but also a metabolic one making a better understanding of adipocytokines in their afferent and efferent pathways ...
Jose Antonio Robles-Cervantes +3 more
openaire +1 more source
The subcutaneous abdominal fat comprehends two-thirds of the total abdominal fat, for being more abundant than visceral fat; it has a more important role in endocrine function. Subcutaneous fat removal by liposuction has an esthetic effect but also a metabolic one making a better understanding of adipocytokines in their afferent and efferent pathways ...
Jose Antonio Robles-Cervantes +3 more
openaire +1 more source
Visfatin and its role in obesity development
Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2012Visfatin, a product of PBEF gene, is an adipocytokine that harbours strong insulin-mimetic activity and it has been reported previously to associate with obesity. Recent reports also provide evidence that Visfatin has also important intracellular effects as it is homologous with nicotinamide phosphoribosyltransferase (NAMPT).
Julie Bienertova Vasku, Anna Vašků
exaly +3 more sources
Visfatin as a therapeutic target for rheumatoid arthritis
Expert Opinion on Therapeutic Targets, 2019Introduction: The rising prevalence of musculoskeletal pathologies in developed countries has caused a dramatic impact on social welfare. Amidst these musculoskeletal pathologies is Rheumatoid arthritis (RA), a chronic systemic autoimmune disease that mostly affects the synovium.
Eloi Franco-Trepat +6 more
openaire +2 more sources
Visfatin—a proinflammatory adipokine—in gallstone disease
The American Journal of Surgery, 2010Visfatin is increasingly associated with several obesity-related diseases. The study is to evaluate if aberrant expression of circulating visfatin occurs in gallstone disease.An enzyme-linked immunosorbent assay was used to examine serum visfatin levels in 79 patients with cholesterol gallstones, 71 with pigment gallstones, and 223 healthy controls ...
Shen-Nien, Wang +6 more
openaire +2 more sources
Serum concentration of visfatin in obese women
Metabolism, 2007The aim of the present study was to determine serum concentrations of visfatin in obese women in comparison to normal-weight controls. Study subjects were 21 obese women without additional disease (age, 29.0+/-4.9 years; body mass index, 37.1+/-6.1 kg/m2) and 16 healthy, normal-weight women (age, 29.9+/-5.4 years; body mass index, 22.5+/-1.7 kg/m2 ...
Barbara, Zahorska-Markiewicz +7 more
openaire +2 more sources
Visfatin and endothelial function in dialyzed patients
Nephrology, 2010ABSTRACT:Aim: Visfatin is an adipocytokine that has recently generated much interest. The aim of the study was to assess visfatin in correlation with markers of endothelial damage and inflammation in haemodialyzed and peritoneally dialyzed patients.Methods: Visfatin, leptin, apelin and adiponectin, markers of coagulation (thrombin–antithrombin ...
Jolanta, Malyszko +2 more
openaire +2 more sources
Alzheimers Disease, Ceramide, Visfatin and NAD
CNS & Neurological Disorders - Drug Targets, 2008This review discusses new mechanisms for the induction of Alzheimer's disease, involving lipid toxicity and adipokines. Ceramide induces oxidative stress and the formation of amyloid beta. Visfatin induces oxidative stress, damages the blood brain barrier and increases the attraction of monocytes, neutrophils and other white blood cells.
openaire +2 more sources
Visfatin and gallstone disease
The American Journal of Surgery, 2012Teoman, Dogru +4 more
openaire +2 more sources
The tale of visfatin – comparative analysis of molecual and biological features of human visfatin
Diabetologie und Stoffwechsel, 2007A Körner +4 more
openaire +1 more source
Serum concentration of visfatin and mRNA visfatin expression in adipose tissue in preadolescent boy
2014Pretilost dječije dobi je alarmantan javnozdravstevni problem obzirom na veliki potencijal razvoja bolesti uzrokovanih debljinom u odrasloj dobi. Visfatin, kao marker ateroskleroze, prema dosadašnjim istražiivanjima predominantno se sintetizira u visceralnom tkivu u odrasloj dobi.
Matić, Anita +3 more
openaire